-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BrkzOGMEV6L9AW7dP/1YtbdXecEvnqX9W6O0KBehZNLRuY6d1K5tXYp6MkeM/iCD yMUm/4Bj8bUkhqsa/7xQ5A== 0001104659-04-026078.txt : 20040827 0001104659-04-026078.hdr.sgml : 20040827 20040827141108 ACCESSION NUMBER: 0001104659-04-026078 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 4 FILED AS OF DATE: 20040827 DATE AS OF CHANGE: 20040827 EFFECTIVENESS DATE: 20040827 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CEPHALON INC CENTRAL INDEX KEY: 0000873364 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 232484489 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-118611 FILM NUMBER: 041001994 BUSINESS ADDRESS: STREET 1: 145 BRANDYWINE PKWY CITY: WEST CHESTER STATE: PA ZIP: 19380 BUSINESS PHONE: 6103440200 MAIL ADDRESS: STREET 1: 145 BRANDYWINE PARKWAY CITY: WEST CHESTER STATE: PA ZIP: 19380 S-8 1 a04-9965_1s8.htm S-8

As filed with the Securities and Exchange Commission on August 27, 2004

 

Registration No. 333-

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 

FORM S-8

 

REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933

 

CEPHALON, INC.

(Exact name of issuer as specified in its charter)

 

Delaware

 

23-2484489

(State or other jurisdiction of
incorporation of organization)

 

(I.R.S. Employer Identification No.)

 

 

 

145 Brandywine Parkway
West Chester, Pennsylvania 19380

(Address of principal executive offices)

 

CEPHALON, INC. 2004 EQUITY COMPENSATION PLAN

(Full title of the plan)

 

John E. Osborn, Esq.

Senior Vice President, General Counsel & Secretary

Cephalon, Inc.

145 Brandywine Parkway

West Chester, PA 19380

(Name and address of agent for service)

 

(610) 344-0200

(Telephone number, including area code, of agent for service)

 

Copy to:

Richard A. Silfen, Esq.

Morgan, Lewis & Bockius LLP

1701 Market Street

Philadelphia, PA  19103

(215) 963-5000

 

CALCULATION OF REGISTRATION FEE

 

Title of class of securities
to be registered

 

Amount to be registered
(1)

 

Proposed maximum offering
price per share  (2)

 

Proposed maximum
Aggregate offering price (2)

 

Amount of registration
fee

Common stock, $0.01 par value (3)

 

1,300,000 shares

 

$45.35

 

$58,955,000

 

$7,469.60

 

(1)                                  Pursuant to Rule 416 under the Securities Act of 1933, this Registration Statement also covers such additional shares as may hereinafter be offered or issued to prevent dilution resulting from stock splits, stock dividends and similar anti-dilution provisions.

 

(2)                                  Estimated pursuant to paragraphs (c) and (h) of Rule 457 solely for purposes of calculating the registration fee, based upon the average of the high and low sales price for a share of Common Stock on August 24, 2004, as reported on the Nasdaq National market.

 

(3)                                  Each share of the registrant’s common stock includes one preferred share purchase right pursuant to the Second Amended and Restated Rights Agreement dated October 27, 2003 between Cephalon, Inc. and StockTrans, Inc., as Rights Agent.

 

 



 

PART II

 

INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

 

This registration statement on Form S-8 relates to the registration of an additional 1,300,000 shares of Common Stock, $.01 par value, of the Registrant.  The shares are securities of the same class and relating to the same employee benefit plan, the Cephalon, Inc. 2004 Equity Compensation Plan (previously known as the Cephalon, Inc. 1995 Equity Compensation Plan), as those shares registered in the Registrant’s registration statement on Forms S-8, previously filed with the Securities and Exchange Commission on March 28, 1996, December 23, 1998, October 29, 1999, May 28, 2002 and June 13, 2003.  The earlier registration statements on Form S-8 (Registration Nos. 333-02888, 333-69591, 333-89909, 333-89230 and 333-106112) are hereby incorporated by reference.

 

Independent Accountants

 

The consolidated financial statements of Cephalon, Inc. for the years ended December 31, 2003, 2002 and 2001 included in the Annual Report on Form 10-K for the year ended December 31, 2003, incorporated by reference in this Registration Statement, have been audited by PricewaterhouseCoopers LLP, independent public accountants, as stated in their report with respect thereto.

 

Item 8.           Exhibits.

 

The following exhibits are filed as part of this registration statement:

 

Exhibit
Number

 

Exhibit

 

 

 

5.1*

 

Opinion of Morgan, Lewis & Bockius LLP

 

 

 

23.1*

 

Consent of Morgan, Lewis & Bockius LLP (included in its opinion filed as Exhibit 5.1 hereto)

 

 

 

23.2*

 

Consent of PricewaterhouseCoopers LLP

 

 

 

99.1*

 

Amendment 2004 – 1 to the Cephalon, Inc. 2004 Equity Compensation Plan, dated February 5, 2004

 

 

 

99.2

 

Cephalon, Inc. 1995 Equity Compensation Plan, as amended and restated, filed as Exhibit 99.1 to the Company’s Registration Statement on Form S-8 (333-106112) dated June 13, 2003.

 


*                                         Filed herewith.

 

1



 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of West Chester, Commonwealth of Pennsylvania, on this 27th day of August 2004.

 

 

 

CEPHALON, INC.

 

 

 

By:

 /s/ Frank Baldino, Jr.

 

 

 

Frank Baldino, Jr., Ph.D.

 

 

Chairman and Chief Executive Officer

 

 

Pursuant to the requirements of the Securities Act of 1933, as amended, this Registration Statement has been signed below by the following persons in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

/s/ Frank Baldino, Jr

 

Chairman and Chief Executive

August 27, 2004

Frank Baldino, Jr., Ph.D.

 

Officer (Principal Executive Officer)

 

 

 

 

 

/s/ J. Kevin Buchi

 

Sr. Vice President and Chief Financial

August 27, 2004

J. Kevin Buchi

 

Officer (Principal Financial and
Accounting Officer)

 

 

 

 

 

/s/ William P. Egan

 

Director

August 27, 2004

William P. Egan

 

 

 

 

 

 

 

/s/ Robert J. Feeney

 

Director

August 27, 2004

Robert J. Feeney, Ph.D.

 

 

 

 

 

 

 

/s/ Martyn D. Greenacre

 

Director

August 27, 2004

Martyn D. Greenacre

 

 

 

 

 

 

 

/s/ Charles A. Sanders

 

Director

August 27, 2004

Charles A. Sanders

 

 

 

 

 

 

 

/s/ Gail R. Wilensky

 

Director

August 27, 2004

Gail R. Wilensky, Ph.D

 

 

 

 

 

 

 

/s/ Dennis L. Winger

 

Director

August 27, 2004

Dennis L. Winger

 

 

 

 

 

 

 

/s/ Horst Witzel

 

Director

August 27, 2004

Horst Witzel, Dr.-Ing

 

 

 

 

2



 

Cephalon, Inc.

 

INDEX

 

Exhibit Number

 

Description

 

 

 

5.1

 

Opinion of Morgan, Lewis & Bockius LLP

23.2

 

Consent of PricewaterhouseCoopers LLP

99.1

 

Amendment 2004 – 1 to the Cephalon, Inc. 2004 Equity Compensation Plan, effective as of February 5, 2004

 

3


EX-5.1 2 a04-9965_1ex5d1.htm EX-5.1

Exhibit 5.1

 

[Letterhead of Morgan, Lewis & Bockius LLP]

 

August 27, 2004

 

 

Cephalon, Inc.

145 Brandywine Parkway

West Chester, PA  19380

 

RE:                              Cephalon, Inc. – Registration Statement on Form S-8 Relating to the Cephalon, Inc. 2004 Equity Compensation Plan

 

Ladies and Gentlemen:

 

We have acted as counsel to Cephalon, Inc., a Delaware corporation (the “Company”), in connection with the filing of the above-referenced Registration Statement (the “Registration Statement”) under the Securities Act of 1933, as amended (the “Act”), with the Securities and Exchange Commission (the “SEC”).  The Registration Statement relates to an aggregate of 1,300,000 additional shares (the “Shares”) of the Company’s common stock, par value $0.01 per share, issuable under the Cephalon, Inc. 2004 Equity Compensation Plan, as amended, effective as of February 5, 2004 (the “Plan”).

 

In connection with this opinion letter, we have examined the Registration Statement and originals, or copies certified or otherwise identified to our satisfaction, of the Restated Certificate of Incorporation, as amended, and Bylaws, as amended and restated, of the Company, the Plan and such other documents, records and other instruments as we have deemed appropriate for purposes of the opinion set forth herein.

 

We have assumed the genuineness of all signatures, the legal capacity of all natural persons, the authenticity of the documents submitted to us as originals, the conformity with the originals of all documents submitted to us as certified, facsimile or photostatic copies and the authenticity of the originals of all documents submitted to us as copies.

 

Based upon the foregoing, we are of the opinion that the Shares to be issued by the Company to participants under the Plan have been duly authorized by the Company and, when issued and delivered by the Company to participants under the Plan in accordance with the terms of the Plan, will be validly issued, fully paid and non-assessable.

 

The opinions expressed herein are limited to the Delaware General Corporation Law.

 

We hereby consent to the use of this opinion as Exhibit 5.1 to the Registration Statement.  In giving such consent, we do not hereby admit that we are acting within the category of persons whose consent is required under Section 7 of the Act or the rules or regulations of the SEC thereunder.

 

Very truly yours,

 

/s/ Morgan, Lewis & Bockius LLP

 

 


EX-23.2 3 a04-9965_1ex23d2.htm EX-23.2

EXHIBIT 23.2

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 11, 2004, relating to the financial statements and financial statement schedules, which appear in Cephalon, Inc.’s Annual Report on Form 10-K for the fiscal year ended December 31, 2003.

 

 

/s/ PricewaterhouseCoopers LLP

 

 

Philadelphia, PA

August 27, 2004

 


EX-99.1 4 a04-9965_1ex99d1.htm EX-99.1

EXHIBIT 99.1

 

AMENDMENT 2004-1

 

TO THE

 

CEPHALON, INC.

 

1995 EQUITY COMPENSATION PLAN

 

1.                                       Effective as of February 5, 2004, the name of the Plan shall be changed to the “Cephalon, Inc. 2004 Equity Compensation Plan” and all references in the Plan to the “Cephalon, Inc. 1995 Equity Compensation Plan” shall be revised accordingly.

 

2.                                       Effective as of February 5, 2004, subject to the approval of the Company’s stockholders, the first sentence of Section 3(a) of the Plan shall be amended in its entirety to read as follows:

 

“Subject to adjustment as described below, the aggregate number of shares of common stock of the Company (“Company Stock”) that may be issued or transferred under the Plan is 4,700,000 shares and, (i) effective February 1, 2002, the aggregate number of shares of Company Stock that may be issued or transferred under the Plan shall be increased by 1,200,000 shares so that the total number of shares of Company Stock authorized for issuance or transfer under the Plan shall be 5,900,000 shares; provided, however, that no more than 100,000 of these additional shares of Company Stock shall be available for issuance as Stock Awards, (ii) effective February 6, 2003, the aggregate number of shares of Company Stock that may be issued or transferred under the Plan shall be increased by 2,500,000 shares so that the total number of shares of Company Stock authorized for issuance or transfer under the Plan shall be 8,400,000 shares; provided, however, that no more than 100,000 of these additional shares of Company Stock shall be available for issuance as Stock Awards, and (iii) effective February 5, 2004, the aggregate number of shares of Company Stock that may be issued or transferred under the Plan shall be increased by 1,300,000 shares so that the total number of shares of Company Stock authorized for issuance or transfer under the Plan shall be 9,700,000 shares; provided, however, that no more than 500,000 of these additional shares of Company Stock shall be available for issuance as Stock Awards.”

 

3.                                       Effective as of February 5, 2004, subject to the approval of the Company’s stockholders, Section 12(b) of the Plan shall be amended in its entirety to read as follows:

 

“(b)                           Termination of Plan.  The Plan shall terminate on the day immediately preceding the tenth anniversary of February 5, 2004, unless

 



 

the Plan is terminated earlier by the Board or is extended by the Board with the approval of the stockholders.”

 

4.                                       As thus amended, the Plan is hereby ratified, republished and reconfirmed and said Plan and this amendment thereto hereby constitute the Plan.

 


-----END PRIVACY-ENHANCED MESSAGE-----